Related Experiment Video
Updated: May 24, 2026
05:40
The Motivation for Alcohol Reward: Predictors of Progressive-Ratio Intravenous Alcohol Self-Administration in Humans
Published on: April 28, 2022
High-dose baclofen for treatment-resistant alcohol dependence
Adam Pastor1, David Martyn Lloyd Jones, Jon Currie
1Department of Addiction Medicine, St Vincent's Hospital, Melbourne, Australia. adampastor@yahoo.com
Journal of Clinical Psychopharmacology
|February 28, 2012
Summary
High-dose baclofen may help alcohol-dependent patients resistant to standard treatments. This study explored higher baclofen dosages (75-125 mg daily) in four treatment-resistant individuals, showing promising results for alcohol abstinence.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Alcohol dependence presents significant global health challenges, leading to numerous physical and psychiatric issues.
- Baclofen, at standard doses (30 mg daily), has shown efficacy in clinical trials for reducing alcohol craving and promoting abstinence.
- Treatment resistance is a common challenge in managing alcohol dependence.
Observation:
- Individual case reports suggest higher baclofen doses might benefit treatment-resistant patients.
- This study investigated the effects of high-dose baclofen (75-125 mg daily) in four patients with alcohol dependence.
- These patients were resistant to conventional alcohol dependence treatments.
Findings:
- All four treatment-resistant patients demonstrated positive responses to higher baclofen dosages.
- The observed effects suggest a potential dose-dependent efficacy of baclofen in alcohol dependence.
- Higher baclofen doses may offer a viable therapeutic option for refractory cases.
Implications:
- Further research is warranted to confirm the efficacy and safety of high-dose baclofen for treatment-resistant alcohol dependence.
- High-dose baclofen could represent a novel therapeutic strategy for a challenging patient population.
- These findings may inform future clinical guidelines for managing severe alcohol dependence.
More Related Videos
Related Concept Videos
01:27CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
01:29Drug Delivery: Parenteral Route
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
01:14CNS Depressants: Barbiturates and Benzodiazepines
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
01:26Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...